Skip to content

Clinical trials

Pulmonary Embolism trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Country / region: Switzerland Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20074
20083
20091
20102
20111
20131
20143
20151
20161
20172
20182
20191
20205
20213
20223
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting6
Terminated6
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
Boston Scientific Corporation4
Inari Medical4
Insel Gruppe AG, University Hospital Bern4
University Hospital, Geneva4
Anthos Therapeutics, Inc.2
Ottawa Hospital Research Institute2
University Hospital, Basel, Switzerland2
University of Zurich2
Assistance Publique - Hôpitaux de Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism42
Venous Thrombosis12
Venous Thromboembolism10
Embolism and Thrombosis5
Thromboembolism5
Embolism4
Thrombosis4
Cardiovascular Diseases3
Atrial Fibrillation2
COVID-192

Trials

Showing 51 to 42 of 42. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.